This document, released on April 13, is a valuable resource for industry professionals primarily because of its excellent and detailed summary of reports, reviews, and peer-reviewed articles on this controversial subject. Critics of antimicrobial use in food-producing animals are unlikely to be satisfied by the two relatively weak principles articulated in the Guidance Document.

We post below the Guidance Document and the associated FDA Strategy Statement and Q&A: